Development and utilization of the patient knowledge questionnaire on botulinum toxin use in movement disorders

Schoffer, Kerrie L.; O’Maley, Karen; O’Sullivan, John D.

doi:10.1016/j.jocn.2006.03.021

Cited by 2 publications

(6 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…15 Issues regarding safety and adverse events have been identified to be the most important educational topic for patients' knowledge on BTX use in movement disorders. 16 BTX-A is now regarded with some confidence as a safe and effective intervention for a variety of therapeutic indications. 17,18 Even in high doses (≥ is 15 U/kg bodyweight or ≥ is 800 total units) it has been identified to be safe for the treatment of spasticity in children and young adults.…”

mentioning

confidence: 99%

Repeat injection of botulinum toxin A is safe and effective for upper limb movement and function in children with cerebral palsy

Lowe

Novak

Cusick

2007

Develop Med Child Neuro

View full text Add to dashboard Cite

The efficacy of repeated botulinum toxin A (BTX‐A) injections in two and three dose regimes, together with occupational therapy, on upper limb movement and function, was studied using an evaluator blinded, randomized, controlled two‐group trial. Forty‐two children (31 males, 11 females; range 2–8y, mean 4y [SD 1y 7mo]) with hemiplegic cerebral palsy (Gross Motor Function Classification System Level I) longitudinally participated for 30 months, with the first 6 months reported earlier (Lowe et al. 2006). The BTX‐A group (n=21) received three injections (0, 6, and 18mo), while the delayed group had two (6 and 18mo; dose 0.5‐2.1 units/kg, mean 1.5 [SD 0.18]; dilution 100 units/0.5ml). At 30 months, no difference existed between groups on any standardized measures. First and second injections showed significant treatment effect sizes, on Quality of Upper Extremity Skills Test (5.5 p=0.01: 4.5 p=0.03); parent Goal Attainment Scaling (GAS; 3.5 p=0.02: 3.9 p=0.01; therapist GAS 7.8 p=0.00: 4.0 p=0.03); Canadian Occupational Performance Measure (performance 0.4 p=0.05: 0.4 p=0.02; satisfaction 0.4 p=0.05: 0.37 p=0.08); and Pediatric Evaluation of Disability Inventory functional skills (1.8 p=0.00: 2.3 p=0.04). BTX‐A was not linked to adverse events, suggesting repeated upper limb injections in children with hemiplegia receiving occupational therapy were safe and effective for improvement of movement and function.

show abstract

mentioning

confidence: 99%

Repeat injection of botulinum toxin A is safe and effective for upper limb movement and function in children with cerebral palsy

Lowe

Novak

Cusick

2007

Develop Med Child Neuro

View full text Add to dashboard Cite

show abstract

“…All subjects underwent detailed demographic, clinical, and questionnaire-based evaluations of knowledge, attitudes, and perceptions according to a structured protocol. During the interview, the Patient Knowledge Questionnaire on Botulinum Toxin Use in Movement Disorders (PKQ-BMD) questionnaire was applied in a language that participants found familiar and comfortable for comprehending and giving an appropriate response [ 10 ]. The questionnaire had four domains, namely, general knowledge, expectations, pathophysiology, and adverse effects.…”

Section: Methodsmentioning

confidence: 99%

“…The questionnaire had four domains, namely, general knowledge, expectations, pathophysiology, and adverse effects. The initially designed questionnaire by Schoffer et al [ 10 ] had two responses: “Right” and “Wrong.” We modified it for the Indian population and added another response, “No idea (do not know),” which indicated a lack of knowledge about the question that was asked. We used the third response to avoid bias.…”

Section: Methodsmentioning

confidence: 99%

“…Gradually, the usage of BoNT has spread worldwide, but there is limited literature available on the knowledge, attitude, and perceptions (KAP) of BoNT treatment among patients and caregivers globally [ 10 ].…”

mentioning

confidence: 99%

“…Hence, studies are required to know the existing knowledge among patients receiving BoNT to focus on education related to its use, the fears and apprehensions of adverse effects, its duration and mechanism of action, and the frequency of injections before starting the treatment [ 10 , 11 ]. Thus, we planned to study the knowledge, attitude, and perception of patients with movement disorders coming to a tertiary care center in South India for BoNT treatment.…”

mentioning

confidence: 99%

See 2 more Smart Citations

Patient Knowledge, Attitude and Perceptions towards Botulinum Toxin Treatment for Movement Disorders in India

Mol

Kamble

Holla

et al. 2021

JMD

View full text Add to dashboard Cite

Objective There is limited literature on the knowledge, attitude, and perceptions (KAP) of botulinum toxin (BoNT) treatment among patients and caregivers. The objective of this study was to assess the KAP in patients undergoing BoNT treatment for movement disorders. Methods One hundred patients with movement disorders from National Institute of Mental Health and Neurosciences Hospital in Bengaluru, South India, were recruited. The patients underwent demographic, clinical, and Patient Knowledge Questionnaire on Botulinum Toxin Use in Movement Disorders (PKQ-BMD)-based evaluations. Results The mean age of patients at the time of presentation was 47.97 ± 14.19 years (range, 12–79). Of all the patients, 26 (28%) patients were anxious, and 86% of these patients were reassured after appropriate counseling. There were 83 (89%) patients who found BoNT to be a costlier option. Education and previous Internet searches influenced positive performance in the “knowledge” domain and overall PKQ-BMD scores. The “number of injections” was also positively correlated with KAP performance. Conclusion This study showed that knowledge and perceptions about BoNT treatment need to be further improved. Wider availability of the Internet has provided a positive impact on patients’ and carers’ KAP. Internet-based information, higher educational qualifications of the patients, and a higher number of BoNT injection sessions are the most important predictors of satisfactory KAP related to BoNT injection treatment in patients with movement disorders.

show abstract

Development and utilization of the patient knowledge questionnaire on botulinum toxin use in movement disorders

Cited by 2 publications

References 3 publications

Repeat injection of botulinum toxin A is safe and effective for upper limb movement and function in children with cerebral palsy

Repeat injection of botulinum toxin A is safe and effective for upper limb movement and function in children with cerebral palsy

Patient Knowledge, Attitude and Perceptions towards Botulinum Toxin Treatment for Movement Disorders in India

Contact Info

Product

Resources

About